SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-21-071615
Filing Date
2021-03-05
Accepted
2021-03-05 17:01:04
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC14D9C d112091dsc14d9c.htm SC14D9C 20424
2 EX-99.1 d112091dex991.htm EX-99.1 26329
3 GRAPHIC g112091g0305221131478.jpg GRAPHIC 3584
  Complete submission text file 0001193125-21-071615.txt   53639
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filed by) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-87623 | Film No.: 21719361
SIC: 2834 Pharmaceutical Preparations